(EVK) Evonik Industries - Ratings and Ratios

Exchange: XETRA • Country: Germany • Currency: EUR • Type: Common Stock • ISIN: DE000EVNK013

EVK: Specialty Chemicals, Additives, Polymers, Catalysts, Pharmaceuticals

Evonik Industries AG (XETRA:EVK) is a global leader in the production of specialty chemicals, serving diverse markets across Asia-Pacific, Europe, the Middle East, Africa, Central and South America, and North America. The company operates through four core segments: Specialty Additives, Nutrition & Care, Smart Materials, and Technology & Infrastructure.

The Specialty Additives segment provides a range of high-performance additives, including polyurethane foam additives, coatings and paint additives, isophorone and epoxy curing agents, and lubricant additives for automotive and construction sectors. The Nutrition & Care segment focuses on animal nutrition products like D-/l-methionine and lysine, pharmaceutical active ingredients, medical products such as biocompatible materials, and system solutions for cosmetics and detergents. The Smart Materials segment offers inorganic materials like silicas and silanes, peroxides, specialty catalysts, and polymer products such as polyamide 12 and polymer foams. The Technology & Infrastructure segment delivers energy management, plant maintenance, process safety, logistics, and digital solutions for chemical production.

Founded in 1847 and headquartered in Essen, Germany, Evonik Industries AG has established itself as a key player in the specialty chemicals industry, with a strong emphasis on innovation and sustainability. Web URL: https://evonik.com

Ticker Symbol: EVK Exchange: XETRA Type: common stock Country Origin: Germany GICS Sub Industry: Specialty Chemicals Average Volume 20d: 1121031 Last Price: 19.35 SMA 20: 19.14 SMA 50: 19.84 SMA 200: 19.09 ATR: 0.59 Market Cap: 8728.18M EUR P/E: 39.02 P/E Forward: 19.92 P/B: 0.97 P/S: 0.58 RoE: 2.46 3-Month Forecast Based on the provided and , the stock is expected to trade in a narrow range with potential upside due to its low P/S ratio and improving SMA trends. However, the high P/E ratio and low RoE may limit significant price appreciation.

Additional Sources for EVK Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

EVK Stock Overview

Market Cap in USD 9,882m
Sector Basic Materials
Industry Specialty Chemicals
GiC Sub-Industry Specialty Chemicals
IPO / Inception

EVK Stock Ratings

Growth Rating -6.83
Fundamental 0.11
Dividend Rating 80.3
Rel. Strength 11.3
Analysts -
Fair Price Momentum 20.23 EUR
Fair Price DCF 38.68 EUR

EVK Dividends

Dividend Yield 12m 12.07%
Yield on Cost 5y 14.20%
Annual Growth 5y 0.35%
Payout Consistency 96.7%

EVK Growth Ratios

Growth Correlation 3m 6.4%
Growth Correlation 12m -2.7%
Growth Correlation 5y -41.4%
CAGR 5y 3.63%
CAGR/Max DD 5y 0.09
Sharpe Ratio 12m 0.78
Alpha -1.56
Beta 0.325
Volatility 29.47%
Current Volume 1192.6k
Average Volume 20d 1078.7k
What is the price of EVK stocks?
As of May 01, 2025, the stock is trading at EUR 19.75 with a total of 1,192,634 shares traded.
Over the past week, the price has changed by +2.07%, over one month by -0.93%, over three months by +8.91% and over the past year by +7.42%.
Is Evonik Industries a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Evonik Industries is currently (May 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 0.11 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of EVK as of May 2025 is 20.23. This means that EVK is currently overvalued and has a potential downside of 2.43%.
Is EVK a buy, sell or hold?
Evonik Industries has no consensus analysts rating.
What are the forecast for EVK stock price target?
According to ValueRays Forecast Model, EVK Evonik Industries will be worth about 21.9 in May 2026. The stock is currently trading at 19.75. This means that the stock has a potential upside of +10.63%.
Issuer Forecast Upside
Wallstreet Target Price 21.6 9.3%
Analysts Target Price - -
ValueRay Target Price 21.9 10.6%